| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 124, 40-48, Copyright © 1989 by Endocrine Society
ARTICLES |
CJ Quaife, LS Mathews, CA Pinkert, RE Hammer, RL Brinster and RD Palmiter
Department of Biochemistry, University of Washington, Seattle 98195.
Serum levels of GH and insulin-like growth factor I (IGF-I) were genetically increased to investigate the physiological activities of these proteins. Lines of mice expressing chimeric genes composed of bovine GH, human GRF, or human IGF-I coding sequences fused to the mouse metallothionein I promoter were examined for consequences of chronic exposure to high levels of these peptides. Animals with elevated serum levels of GH (either bovine GH or mouse GH) have selective splanchnomegaly coupled with glomerular sclerosis and hepatocellularmegaly. Serum levels of insulin and cholesterol are increased. In contrast (with the exception of selective enlargement of organs), the chronic expression of IGF-I results in a different pattern of abnormalities. These findings suggest that the pathogenesis of GH- related disorders is not mediated solely by IGF-I.
This article has been cited by other articles:
![]() |
K. Robertson, Y. Lu, K. De Jesus, B. Li, Q. Su, P. K. Lund, and J.-L. Liu A general and islet cell-enriched overexpression of IGF-I results in normal islet cell growth, hypoglycemia, and significant resistance to experimental diabetes Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E928 - E938. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cho, M. Ariga, Y. Uchijima, K. Kimura, J.-Y. Rho, Y. Furuhata, F. Hakuno, K. Yamanouchi, M. Nishihara, and S.-I. Takahashi The Novel Roles of Liver for Compensation of Insulin Resistance in Human Growth Hormone Transgenic Rats Endocrinology, November 1, 2006; 147(11): 5374 - 5384. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Berryman, E. O. List, D. T. Kohn, K. T. Coschigano, R. J. Seeley, and J. J. Kopchick Effect of Growth Hormone on Susceptibility to Diet-Induced Obesity Endocrinology, June 1, 2006; 147(6): 2801 - 2808. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Tannahill, J. Elliott, A. C. Barry, L. Hibbert, N. A. Cacalano, and J. A. Johnston SOCS2 Can Enhance Interleukin-2 (IL-2) and IL-3 Signaling by Accelerating SOCS3 Degradation Mol. Cell. Biol., October 15, 2005; 25(20): 9115 - 9126. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. D. Sharp and A. Bartke Evidence for Down-Regulation of Phosphoinositide 3-Kinase/Akt/Mammalian Target of Rapamycin (PI3K/Akt/mTOR)-Dependent Translation Regulatory Signaling Pathways in Ames Dwarf Mice J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2005; 60(3): 293 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Olsson, M. Bohlooly-Y, S. M. Fitzgerald, F. Frick, A. Ljungberg, B. Ahren, J. Tornell, G. Bergstrom, and J. Oscarsson Bovine Growth Hormone Transgenic Mice Are Resistant to Diet-Induced Obesity but Develop Hyperphagia, Dyslipidemia, and Diabetes on a High-Fat Diet Endocrinology, February 1, 2005; 146(2): 920 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Olsson, M. Bohlooly-Y, O. Brusehed, O. G. P. Isaksson, B. Ahren, S.-O. Olofsson, J. Oscarsson, and J. Tornell Bovine growth hormone-transgenic mice have major alterations in hepatic expression of metabolic genes Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E504 - E511. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yakar and C. J. Rosen From Mouse to Man: Redefining the Role of Insulin-Like Growth Factor-I in the Acquisition of Bone Mass Experimental Biology and Medicine, March 1, 2003; 228(3): 245 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Senthil, G. G. Choudhury, H. E. Abboud, N. Sonenberg, and B. S. Kasinath Regulation of protein synthesis by IGF-I in proximal tubular epithelial cells Am J Physiol Renal Physiol, December 1, 2002; 283(6): F1226 - F1236. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Le Marchand, T. Donlon, A. Seifried, R. Kaaks, S. Rinaldi, and L. R. Wilkens Association of a Common Polymorphism in the Human GH1 Gene with Colorectal Neoplasia J Natl Cancer Inst, March 20, 2002; 94(6): 454 - 460. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Frick, M. Bohlooly-Y, D. Linden, B. Olsson, J. Tornell, S. Eden, and J. Oscarsson Long-term growth hormone excess induces marked alterations in lipoprotein metabolism in mice Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1230 - E1239. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Gooch, Y. Tang, J. M. Ricono, and H. E. Abboud Insulin-like Growth Factor-I Induces Renal Cell Hypertrophy via a Calcineurin-dependent Mechanism J. Biol. Chem., November 2, 2001; 276(45): 42492 - 42500. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wallenius, K. Sjogren, X.-D. Peng, S. Park, V. Wallenius, J.-L. Liu, M. Umaerus, H. Wennbo, O. Isaksson, L. Frohman, et al. Liver-Derived IGF-I Regulates GH Secretion at the Pituitary Level in Mice Endocrinology, November 1, 2001; 142(11): 4762 - 4770. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Krebs and D. J. Hilton SOCS Proteins: Negative Regulators of Cytokine Signaling Stem Cells, September 1, 2001; 19(5): 378 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Melmed CLINICAL PERSPECTIVE: Acromegaly and Cancer: Not a Problem? J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 2929 - 2934. [Full Text] [PDF] |
||||
![]() |
K. Sjogren, K. Wallenius, J.-L. Liu, M. Bohlooly-Y, G. Pacini, L. Svensson, J. Tornell, O. G.P. Isaksson, B. Ahren, J.-O. Jansson, et al. Liver-Derived IGF-I is of Importance for Normal Carbohydrate and Lipid Metabolism Diabetes, July 1, 2001; 50(7): 1539 - 1545. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Molon-Noblot, P. Laroque, S. Prahalada, L. G. Stabinski, C. P. Peter, P. Duprat, and M. J. Van Zwieten Morphological Changes in the Kidney of Dogs Chronically Exposed to Exogenous Growth Hormone Toxicol Pathol, July 1, 2000; 28(4): 510 - 517. [Abstract] [PDF] |
||||
![]() |
E. Bollano, E. Omerovic, M. Bohlooly-Y, V. Kujacic, B. Madhu, J. Tornell, O. Isaksson, B. Soussi, W. Schulze, M. L. X. Fu, et al. Impairment of Cardiac Function and Bioenergetics in Adult Transgenic Mice Overexpressing the Bovine Growth Hormone Gene Endocrinology, June 1, 2000; 141(6): 2229 - 2235. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Liu, S. Yakar, and D. LeRoith Conditional Knockout of Mouse Insulin-Like Growth Factor-1 Gene Using the Cre/loxP System Experimental Biology and Medicine, April 1, 2000; 223(4): 344 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Frick, J. Oscarsson, K. Vikman-Adolfsson, M. Ottosson, N. Yoshida, and S. Eden Different effects of IGF-I on insulin-stimulated glucose uptake in adipose tissue and skeletal muscle Am J Physiol Endocrinol Metab, April 1, 2000; 278(4): E729 - E737. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Eugster Gigantism J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4379 - 4384. [Full Text] |
||||
![]() |
G. Pete, C. R. Fuller, J. M. Oldham, D. R. Smith, A. J. DErcole, C. R. Kahn, and P. K. Lund Postnatal Growth Responses to Insulin-Like Growth Factor I in Insulin Receptor Substrate-1-Deficient Mice Endocrinology, December 1, 1999; 140(12): 5478 - 5487. [Abstract] [Full Text] |
||||
![]() |
A. Bartke, V. Chandrashekar, D. Turyn, R. W. Steger, L. Debeljuk, T. A. Winters, J. A. Mattison, N. A. Danilovich, W. Croson, D. R. Wernsing, et al. Effects of Growth Hormone Overexpression and Growth Hormone Resistance on Neuroendocrine and Reproductive Functions in Transgenic and Knock-Out Mice Experimental Biology and Medicine, November 1, 1999; 222(2): 113 - 123. [Abstract] [Full Text] |
||||
![]() |
J.-L. Liu and D. LeRoith Insulin-Like Growth Factor I Is Essential for Postnatal Growth in Response to Growth Hormone Endocrinology, November 1, 1999; 140(11): 5178 - 5184. [Abstract] [Full Text] |
||||
![]() |
J. Petrik, J. M. Pell, E. Arany, T. J. McDonald, W. L. Dean, W. Reik, and D. J. Hill Overexpression of Insulin-Like Growth Factor-II in Transgenic Mice Is Associated with Pancreatic Islet Cell Hyperplasia Endocrinology, May 1, 1999; 140(5): 2353 - 2363. [Abstract] [Full Text] |
||||
![]() |
C. Costa, G. Solanes, J. Visa, and F. Bosch Transgenic rabbits overexpressing growth hormone develop acromegaly and diabetes mellitus FASEB J, November 1, 1998; 12(14): 1455 - 1460. [Abstract] [Full Text] |
||||
![]() |
D. S. Franklin, V. L. Godfrey, H. Lee, G. I. Kovalev, R. Schoonhoven, S. Chen-Kiang, L. Su, and Y. Xiong CDK inhibitors p18INK4c and p27Kip1 mediate two separate pathways to collaboratively suppress pituitary tumorigenesis Genes & Dev., September 15, 1998; 12(18): 2899 - 2911. [Abstract] [Full Text] |
||||
![]() |
V. Chandrashekar and A. Bartke The Role of Growth Hormone in the Control of Gonadotropin Secretion in Adult Male Rats Endocrinology, March 1, 1998; 139(3): 1067 - 1074. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, S. Zinkel, K. Polonsky, and E. Fuchs Transgenic studies with a keratin promoter-driven growth hormone transgene: Prospects for gene therapy PNAS, January 7, 1997; 94(1): 219 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Glaser, J Lane, and D Housman A mouse model of the aniridia-Wilms tumor deletion syndrome Science, November 9, 1990; 250(4982): 823 - 827. [Abstract] [PDF] |
||||
![]() |
V. Pursel, C. Pinkert, K. Miller, D. Bolt, R. Campbell, R. Palmiter, R. Brinster, and R. Hammer Genetic engineering of livestock Science, June 16, 1989; 244(4910): 1281 - 1288. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |